CytomX Therapeutics Inc (CTMX)
4.489
-0.64
(-12.49%)
USD |
NASDAQ |
May 02, 16:00
4.44
-0.05
(-1.09%)
After-Hours: 04:33
CytomX Therapeutics Cash from Operations (Quarterly): -21.96M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -21.96M |
| September 30, 2023 | -18.24M |
| June 30, 2023 | -25.18M |
| March 31, 2023 | 9.349M |
| December 31, 2022 | -1.393M |
| September 30, 2022 | -33.84M |
| June 30, 2022 | -34.24M |
| March 31, 2022 | -41.31M |
| December 31, 2021 | -31.19M |
| September 30, 2021 | -29.70M |
| June 30, 2021 | -28.20M |
| March 31, 2021 | -29.94M |
| December 31, 2020 | -17.43M |
| September 30, 2020 | -24.68M |
| June 30, 2020 | 97.10M |
| March 31, 2020 | -49.74M |
| December 31, 2019 | -29.48M |
| September 30, 2019 | -23.32M |
| Date | Value |
|---|---|
| June 30, 2019 | -48.65M |
| March 31, 2019 | -39.03M |
| December 31, 2018 | -28.74M |
| September 30, 2018 | -5.551M |
| June 30, 2018 | -26.62M |
| March 31, 2018 | -14.61M |
| December 31, 2017 | 22.00M |
| September 30, 2017 | -5.738M |
| June 30, 2017 | 173.20M |
| March 31, 2017 | -19.09M |
| December 31, 2016 | 1.936M |
| September 30, 2016 | -14.18M |
| June 30, 2016 | 15.75M |
| March 31, 2016 | -5.54M |
| December 31, 2015 | -8.169M |
| September 30, 2015 | -7.766M |
| June 30, 2015 | -6.111M |
| March 31, 2015 | -5.369M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-49.74M
Minimum
Mar 2020
97.10M
Maximum
Jun 2020
-20.11M
Average
-28.20M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Ocular Therapeutix Inc | -22.45M |
| Bristol-Myers Squibb Co | 2.834B |
| ACADIA Pharmaceuticals Inc | 85.39M |
| Cytokinetics Inc | -74.04M |
| Calidi Biotherapeutics Inc | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 12.87M |
| Cash from Financing (Quarterly) | 0.244M |
| Free Cash Flow | -56.88M |
| Free Cash Flow Per Share (Quarterly) | -0.2726 |
| Free Cash Flow to Equity (Quarterly) | -22.23M |
| Free Cash Flow to Firm (Quarterly) | -22.23M |
| Free Cash Flow Yield | -17.16% |